Comparison of biological materials reveals Raman spectroscopy’s potential for detecting chronic myeloid leukemia.
Raman spectroscopic analysis of blood cells, plasma and serum discriminates CML from healthy samples. Spectral evaluation and data fusion of biofluids and cells demonstrate potential of Raman spectroscopy for future clinical CML studies.
No takes yet. Share an insight, caveat, or question.
Nath et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: